Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
108
TGA:102
CANADA:3
Drug Approvals
RAPIBLYK landiolol hydrochloride 300 mg powder for injection vial (463165)
- Product Name
- RAPIBLYK landiolol hydrochloride 300 mg powder for injection vial
- Approval Date
- Jun 13, 2025
TGA
GLYCERYL TRINITRATE CONCENTRATED INJECTION PHEBRA glyceryl trinitrate 50 mg/10 mL concentrated injection vial (453908)
- Product Name
- GLYCERYL TRINITRATE CONCENTRATED INJECTION PHEBRA glyceryl trinitrate 50 mg/10 mL concentrated injection vial
- Approval Date
- May 22, 2025
TGA
LACERAINE GEL TOPICAL WOUND ANAESTHETIC vial (443931)
- Product Name
- LACERAINE GEL TOPICAL WOUND ANAESTHETIC vial
- Approval Date
- Mar 18, 2024
TGA
BUPIVACAINE 0.25% WITH ADRENALINE 1:400,000 PHEBRA bupivacaine HCl 50 mg/20 mL with adrenaline 50 microgram/20 mL solution for injection vial (408186)
- Product Name
- BUPIVACAINE 0.25% WITH ADRENALINE 1:400,000 PHEBRA bupivacaine HCl 50 mg/20 mL with adrenaline 50 microgram/20 mL solution for injection vial
- Approval Date
- Feb 8, 2024
TGA
BUPIVACAINE 0.5% WITH ADRENALINE 1:200,000 PHEBRA bupivacaine HCl 100 mg/20 mL with adrenaline 100 microgram/20 mL solution for injection vial (373819)
- Product Name
- BUPIVACAINE 0.5% WITH ADRENALINE 1:200,000 PHEBRA bupivacaine HCl 100 mg/20 mL with adrenaline 100 microgram/20 mL solution for injection vial
- Approval Date
- Oct 7, 2022
TGA
PHEBRA CALCIUM GLUCONATE 931 mg/10 mL injection vial (355191)
- Product Name
- PHEBRA CALCIUM GLUCONATE 931 mg/10 mL injection vial
- Approval Date
- May 13, 2021
TGA
BREVIBLOC esmolol hydrochloride 2.5 g powder for injection for infusion vial (310943)
- Product Name
- BREVIBLOC esmolol hydrochloride 2.5 g powder for injection for infusion vial
- Approval Date
- Jan 21, 2020
TGA
Phenasen arsenic trioxide 10mg/mL injection (320783)
- Product Name
- Phenasen arsenic trioxide 10mg/mL injection
- Approval Date
- Jul 25, 2019
TGA
- Prev
- 1
- 2
- 3
- 4
- 5
- 11
- Next
Clinical Trials
No trials found
News
No news found